| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/05/2008 | EP1893039A1 Method for treatment and prevention of respiratory insufficiency |
| 03/05/2008 | EP1830883A4 Methods for inhibiting a decline in learning and/or memory in animals |
| 03/05/2008 | EP1805175B1 Novel azaindole thiazolinones as anti-cancer agents |
| 03/05/2008 | EP1758600A4 Methods and compositions for treating mood disorder |
| 03/05/2008 | EP1732541A4 Cyclic compounds |
| 03/05/2008 | EP1723096A4 Structured triglycerides and emulsions comprising same |
| 03/05/2008 | EP1713797B1 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-ht4 receptor agonistic activity |
| 03/05/2008 | EP1713458B1 Method for enhancing the bioavailability of ospemifene |
| 03/05/2008 | EP1709036B1 Thiazole derivatives as a2b antagonists |
| 03/05/2008 | EP1697362B1 Crf receptor antagonists and methods relating thereto |
| 03/05/2008 | EP1694714B1 Low molecular weight polysaccharides having antithrombotic activity |
| 03/05/2008 | EP1689795A4 Method of manufacture of polyacrolein |
| 03/05/2008 | EP1653943B1 Catechol derivatives for the treatment of cancer |
| 03/05/2008 | EP1644382B1 Cross-linked glycopeptide-cephalosporin antibiotics |
| 03/05/2008 | EP1644351B1 Imidazole derivatives and their use in the treatment of mGluR5 receptor mediated disorders |
| 03/05/2008 | EP1633748B1 Quinoline derivatives as phosphodiesterase inhibitors |
| 03/05/2008 | EP1625129B1 Heterocyclyl-substituted dihydroquinazolines and use thereof as an antiviral agent |
| 03/05/2008 | EP1583504A4 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 03/05/2008 | EP1575926B1 New pyridazin-3(2h)-one derivatives |
| 03/05/2008 | EP1558290A4 Heat pasteurized liquids containing glucosamine |
| 03/05/2008 | EP1490040A4 Anti-inflammatory formulations |
| 03/05/2008 | EP1411919B1 (-)-olivil as antioxidant |
| 03/05/2008 | EP1409501B1 Inositol phosphoglycan derivatives and their medical uses |
| 03/05/2008 | EP1383756B1 Coumarin derivatives to be used as anticoagulants |
| 03/05/2008 | EP1383733B1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 03/05/2008 | EP1368253B1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 03/05/2008 | EP1368020B1 Method for identifying maxi-k channel blockers |
| 03/05/2008 | EP1292289B1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 03/05/2008 | EP1267642B1 Composition comprising resistant starch and unsaturated fats |
| 03/05/2008 | EP1144609B1 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 03/05/2008 | EP1059942B1 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 03/05/2008 | EP1045836B1 Pyridones as src family sh2 domain inhibitors |
| 03/05/2008 | EP0989993B1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 03/05/2008 | CN101137756A Method for the production of hyperbranched polysaccharide fractions |
| 03/05/2008 | CN101137754A Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| 03/05/2008 | CN101137753A Rnai-mediated inhibition of ocular hypertension targets |
| 03/05/2008 | CN101137748A Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 03/05/2008 | CN101137700A Microparticle and pharmaceutical composition |
| 03/05/2008 | CN101137673A Cripto结合分子 Cripto binding molecules |
| 03/05/2008 | CN101137660A Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 03/05/2008 | CN101137659A Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin |
| 03/05/2008 | CN101137658A Antipruritic agent for pruritus caused by multiple sclerosis |
| 03/05/2008 | CN101137657A Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists |
| 03/05/2008 | CN101137656A Crystal forms of an imidazole derivative |
| 03/05/2008 | CN101137655A Androgen receptor modulator compounds and methods |
| 03/05/2008 | CN101137654A Novel salt of quinuclidine derivative |
| 03/05/2008 | CN101137653A Thiazole-4-carboxamide derivatives as MGLUR5 antagonists |
| 03/05/2008 | CN101137651A 哒嗪酮化合物 Pyridazinone compound |
| 03/05/2008 | CN101137650A 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 03/05/2008 | CN101137648A Crystalline and amorphous 4-cyano-n-{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin -1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride |
| 03/05/2008 | CN101137645A Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 03/05/2008 | CN101137644A 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyrid-1-yl)ethyl)isoquinoline besylate salt, preparation and therapeutic use thereof |
| 03/05/2008 | CN101137643A Novel pyridine compounds |
| 03/05/2008 | CN101137639A Flavonoid compounds and uses thereof |
| 03/05/2008 | CN101137638A Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives |
| 03/05/2008 | CN101137634A Semi-synthetic taxane derivatives with antitumor activity |
| 03/05/2008 | CN101137631A Heteroaromatic glucokinase activators |
| 03/05/2008 | CN101137630A Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators |
| 03/05/2008 | CN101137629A Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators |
| 03/05/2008 | CN101137628A Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 03/05/2008 | CN101137626A Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators |
| 03/05/2008 | CN101137625A Cinnamate salts of a beta-2 adrenergic agonist |
| 03/05/2008 | CN101137624A Compounds for inflammation and immune-related uses |
| 03/05/2008 | CN101137623A N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 03/05/2008 | CN101137622A Substituted gamma lactams as therapeutic agents |
| 03/05/2008 | CN101137616A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 03/05/2008 | CN101137615A Phosphate salts of 6-dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexane compounds |
| 03/05/2008 | CN101137414A 多环双酰胺mmp抑制剂 Polycyclic bisamides mmp inhibitors |
| 03/05/2008 | CN101137395A Pharmaceutical composition containing hardly water soluble medicament |
| 03/05/2008 | CN101137388A Anti-adhesion composites and methods os use thereof |
| 03/05/2008 | CN101137387A Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases |
| 03/05/2008 | CN101137386A Method of treating liver cancer |
| 03/05/2008 | CN101137385A The use of thiophosphonoformic acid and nrtis to treat viral infections |
| 03/05/2008 | CN101137384A Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| 03/05/2008 | CN101137383A 增强型比马前列素眼用溶液 Enhanced bimatoprost ophthalmic solution |
| 03/05/2008 | CN101137382A Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 03/05/2008 | CN101137381A Use of 2-anilino-3,4-dihydro-quinazolines as 5HT5a receptor antagonists |
| 03/05/2008 | CN101137380A Quinazolinone t-type calcium channel antagonists |
| 03/05/2008 | CN101137379A Cxcr4 antagonists for the treatment of HIV infection |
| 03/05/2008 | CN101137378A Use of methylnaltrexone and related compounds to treat post-operative gastrointestinal dysfunction |
| 03/05/2008 | CN101137377A Tetracyclic amino and carboxamido compounds and methods of use thereof |
| 03/05/2008 | CN101137376A Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 03/05/2008 | CN101137375A 抗炎化合物 Anti-inflammatory compounds |
| 03/05/2008 | CN101137374A Combination of a steroid sulfatase inhibitor and an ascomycin |
| 03/05/2008 | CN101137373A Pharmaceutical compositions containing a combination of a cannabinoid receptor antagonist compound and an antipsychotic agent |
| 03/05/2008 | CN101137372A Mitotic kinesin inhibitors |
| 03/05/2008 | CN101137371A Process for preparing lansoprazole |
| 03/05/2008 | CN101137370A Liquid formulations for treatment of diseases or conditions |
| 03/05/2008 | CN101137369A Formulations for ocular treatment |
| 03/05/2008 | CN101137368A Roflumilast for the treatment of diabetes mellitus |
| 03/05/2008 | CN101137367A Benazapril and amlodipine besylate for reducing cardiovascular morbidity |
| 03/05/2008 | CN101137366A Compounds for treating autoimmune and demyelinating diseases |
| 03/05/2008 | CN101137365A Pharmaceutical compositions comprising sirolimus and/or an analogue thereof |
| 03/05/2008 | CN101137364A Compositions comprising an epothilone and production methods |
| 03/05/2008 | CN101137363A [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 03/05/2008 | CN101137362A Antifungal compositions comprising sertaconazol and hydrocortisone and/or an antibacterial quinolone compound |
| 03/05/2008 | CN101137361A Potassium channel opener having benzofuroindole skeleton |
| 03/05/2008 | CN101137360A Anti-proliferative combination therapy comprising satraplatin or JM118 and a taxane |
| 03/05/2008 | CN101137359A Methods of treating ear infections |
| 03/05/2008 | CN101137358A Antiviral compositions and methods of use |